AMNIOTICS AB (PUBL) Aktie - Unternehmensdaten & Kurse - SE0015961016 | MoneyPeak

AMNIOTICS AB (PUBL)

Share · SE0015961016 · A3CSHB (XSTO)

No Price

n/a

Share Float & Liquidity

Free Float 65,11 %

Shares Float 1,78 B

Shares Outstanding 2,73 B

Company Profile for AMNIOTICS AB (PUBL) Share

Amniotics AB (publ) develops, manufactures, and sells stem cell therapies based on mesenchymal stem cells to treat severe life-threatening diseases. The company's lead drug candidate is PulmoStem for the treatment of inflammatory and fibrotic lung disease. It also develops CogniStem for the treatment of CNS indications; NephroStem for the treatment of kidney-specific indications; and CutiStem for the treatment of dermatological indications. The company offers contract development and contract manufacturing services for advanced therapy medicinal products to the pharmaceutical industries, universities, and hospitals. Amniotics AB (publ) was incorporated in 2015 and is based in Lund, Sweden.

Company Data

Name AMNIOTICS AB (PUBL)

Company Amniotics AB (publ)

Website https://www.amniotics.com

Primary Exchange

Frankfurt

WKN A3CSHB

ISIN SE0015961016

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Marcus Larsson

Market Capitalization 15 Mio

Country Sweden

Currency EUR

Employees 0,0 T

Address ScheelevAegen 2, 22381 Lund

IPO Date 2021-07-06

Ticker Symbols

Name	Symbol
NASDAQ STOCKHOLM AB	AMNI.ST
Frankfurt	66J.F

More Shares

Investors who hold AMNIOTICS AB (PUBL) also have the following shares in their portfolio:

BAYER AG 2024/2054 Bond

GURIT AG SF 50 Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2025